RecruitingNot Applicable

Assessment of DOT Spectacles in Chinese Children Extension

China175 participantsStarted 2025-08-01

Plain-language summary

This is a randomized, controlled, open-label, evaluator-blinded, multicenter, clinical trial of 12-months duration to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses in reducing the progression of juvenile myopia in children of Chinese origin.

Who can participate

Age range8 Years – 16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Previously a successfully completed participant in the CATHAY study (NCT05562622)
✓. Agree to wear the assigned spectacles constantly except for sleeping, swimming, or other activities in which spectacle wear would be dangerous or otherwise not possible (minimum of 10 hours per day)
✓. Willingness to participate in the trial for 12 months without contact lens wear or any other myopia management intervention
✓. The subject's parent(s) or legal guardian(s) must read, understand and sign the Statement of Informed Consent and receive a fully executed copy of the form

What they're measuring

Axial length Group I

Timeframe: 12 months

Axial length Group II

Timeframe: 12 months

Trial details

NCT IDNCT07008001

SponsorSightGlass Vision, Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2026-09-30

Contact for this trial

Jennifer S Hill, BS

678-361-4877 jhill@sightglassvision.com

View on ClinicalTrials.gov More Juvenile Myopia trials